Tamer I. Khayal - Feb 28, 2023 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role
Chief Commercial Officer
Signature
By: /s/ Stephen Gordon, Attorney-in-Fact
Stock symbol
TMDX
Transactions as of
Feb 28, 2023
Transactions value $
-$1,040,400
Form type
4
Date filed
3/2/2023, 04:00 PM
Previous filing
Feb 27, 2023
Next filing
Apr 25, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Options Exercise $161K +10K +69.57% $16.14* 24.4K Feb 28, 2023 Direct F1
transaction TMDX Common Stock Sale -$802K -10K -41.03% $80.15 14.4K Feb 28, 2023 Direct F1, F2, F3
transaction TMDX Common Stock Sale -$400K -5K -20.18% $80.06 19.8K Feb 28, 2023 By the Khayal Family 2021 Irrevocable Trust F1, F4
holding TMDX Common Stock 11.1K Feb 28, 2023 By the Tamer Ibrahim Ahmed Khayal Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -10K -21.62% $0.00 36.2K Feb 28, 2023 Common Stock 10K $16.14 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $80.00 to $80.85, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F4 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $80.00 to $80.24, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F5 The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020.